Yuxin Zhou

Dr. Yuxin Zhou


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2018 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YYYuyuan Yao
Yuyuan Yao
QGQinglong Guo
Qinglong Guo
YCYue Cao
Yue Cao
YQYangmin Qiu
Yangmin Qiu
Ren Xiang TanRen Xiang Tan
Ren Xiang Tan
NLNa Lu
Na Lu
Cancer-associated fibroblasts (CAFs) are activated fibroblasts associated with cancer. They have an important role in tumor growth and metastasis. Artemisinin (ART) is a sesquiterpene lactone extracted from Chinese herb qinghao, and artemether (ARM), artesunate (ARS) and dihydroartemisinin (DHA) were synthesized derivatives of artemisinin, which also have anti-malarial and anti-cancer effects such as artemisinin. In this study, we investigated the in-vitro and in-vivo effects of artemisinin derivatives on inactivating cancer-associated fibroblasts and uncovered its underlying mechanism. We demonstrated that ARS and DHA could revert L-929-CAFs and CAFs from activated to inactivated state in vitro. Mechanically, ARS and DHA could suppress TGF-β signaling to inhibit activation of L-929-CAFs and CAFs, and decreased interaction between tumor and tumor microenvironment. The results showed that ARS and DHA could suppress CAFs-induced breast cancer growth and metastasis in the orthotopic model. Conformably, ARS and DHA suppressed TGF-β signaling to inactivate cancer-associated fibroblasts and inhibit cancer metastasis in vivo. Artemisinin derivatives are potential therapeutic agents for the treatment of breast cancer.

23 April 2015 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
KZKai Zhao
Kai Zhao
YZYuxin Zhou
Yuxin Zhou
CQChen Qiao
Chen Qiao
TNTing Ni
Ting Ni
ZLZhiyu Li
Zhiyu Li
LWLibin Wei
Libin Wei
P53 plays important roles in regulating the metabolic reprogramming of cancer, such as aerobic glycolysis. Oroxylin A is a natural active flavonoid with strong anticancer effects both in vitro and in vivo. wt-p53 (MCF-7 and HCT116 cells) cancer cells and p53-null H1299 cancer cells were used. The glucose uptake and lactate production were analyzed using Lactic Acid production Detection kit and the Amplex Red Glucose Assay Kit. Then, the protein levels and RNA levels of p53, mouse double minute 2 (MDM2), and p53-targeted glycolytic enzymes were quantified using Western blotting and quantitative polymerase chain reaction (PCR), respectively. Immunoprecipitation were performed to assess the binding between p53, MDM2, and sirtuin-3 (SIRT3), and the deacetylation of phosphatase and tensin homolog (PTEN). Reporter assays were performed to assess the transcriptional activity of PTEN. In vivo, effects of oroxylin A was investigated in nude mice xenograft tumor-inoculated MCF-7 or HCT116 cells. Here, we analyzed the underlying mechanisms that oroxylin A regulated p53 level and glycolytic metabolism in wt-p53 cancer cells, and found that oroxylin A inhibited glycolysis through upregulating p53 level. Oroxylin A did not directly affect the transcription of wt-p53, but suppressed the MDM2-mediated degradation of p53 via downregulating MDM2 transcription in wt-p53 cancer cells. In further studies, we found that oroxylin A induced a reduction in MDM2 transcription by promoting the lipid phosphatase activity of phosphatase and tensin homolog, which was upregulated via sirtuin3-mediated deacetylation. In vivo, oroxylin A inhibited the tumor growth of nude mice-inoculated MCF-7 or HCT116 cells. The expression of MDM2 protein in tumor tissue was downregulated by oroxylin A as well. These results provide a p53-independent mechanism of MDM2 transcription and reveal the potential of oroxylin A on glycolytic regulation in both wt-p53 and mut-p53 cancer cells. The studies have important implications for the investigation on anticancer effects of oroxylin A, and provide the academic basis for the clinical trial of oroxylin A in cancer patients.

5 October 2022 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
YSYuening Sun
Yuening Sun
WGWenjing Guo
Wenjing Guo
YGYongjian Guo
Yongjian Guo
ZLZhangxing Lin
Zhangxing Lin
DWDechao Wang
Dechao Wang
YZYuxin Zhou
Yuxin Zhou

1 December 2021 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
YGYongjian Guo
Yongjian Guo
LYLiliang Yang
Liliang Yang
WGWenjing Guo
Wenjing Guo
LWLibin Wei
Libin Wei
YZYuxin Zhou
Yuxin Zhou

1 September 2020 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
XCXian Chen
Xian Chen
LWLibin Wei
Libin Wei
LYLiliang Yang
Liliang Yang
WGWenjing Guo
Wenjing Guo
QGQinglong Guo
Qinglong Guo
YZYuxin Zhou
Yuxin Zhou

26 November 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
WLWei Li
Wei Li
HLHao Liu
Hao Liu
JZJie Zheng
Jie Zheng
DWDechao Wang
Dechao Wang
ZWZhiying Wang
Zhiying Wang
YZYuxin Zhou
Yuxin Zhou